To assess the changes in vessels of the eye after using magnesium sulphate in pregnant females with hypertension due to pregnancy
Not Applicable
- Conditions
- Health Condition 1: O141- Severe pre-eclampsia
- Registration Number
- CTRI/2020/05/025083
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
severely pre eclamptic women, 30-38 weeks of gestation who are scheduled to receive MgSO4
Exclusion Criteria
Women with chronic hypertension, eclampsia, chronic renal disease, hyperthyroidism, twin gestation, seizure disorder, noninsulin dependent diabetes mellitus, severe anemia, autoimmune disorders and those with ocular injuries or prior ocular surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in peak ratio after magnesium sulphate administration at 60 minsTimepoint: The change in peak ratio after magnesium sulphate administration at 60 mins
- Secondary Outcome Measures
Name Time Method 1. The baseline ophthalmic artery indices (resistive index, pulsatility index and peak ratio) in severely pre eclamptic women <br/ ><br>2. The change in resistive index after magnesium sulphate administration <br/ ><br>3. The change in pulsalitiy index after magnesium sulphate administration <br/ ><br>Timepoint: 0mins, 60 mins and 24 hours